Cargando…

Screening and identification of key biomarkers in prostate cancer using bioinformatics

Prostate cancer (PCa) is the second most common cancer amongst males worldwide. In the current study, microarray datasets GSE3325 and GSE6919 from the Gene Expression Omnibus database were screened to identify candidate genes that are associated with the progression of PCa. A total of 273 differenti...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Song, Hou, Junqing, Xu, Weibo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896273/
https://www.ncbi.nlm.nih.gov/pubmed/31746380
http://dx.doi.org/10.3892/mmr.2019.10799
_version_ 1783476742771441664
author Li, Song
Hou, Junqing
Xu, Weibo
author_facet Li, Song
Hou, Junqing
Xu, Weibo
author_sort Li, Song
collection PubMed
description Prostate cancer (PCa) is the second most common cancer amongst males worldwide. In the current study, microarray datasets GSE3325 and GSE6919 from the Gene Expression Omnibus database were screened to identify candidate genes that are associated with the progression of PCa. A total of 273 differentially expressed genes (DEGs) were identified, which included 173 downregulated genes and 100 upregulated genes, and a protein-protein interaction network was constructed using Search Tool for the Retired of Interacting Genes. The enriched functions and pathways of the identified DEGs included cell adhesion, the negative regulation of cell proliferation, protein binding and focal adhesion. A total of 8 hub genes were identified, of which PDZ binding kinase, Krüppel-like factor 4, collagen type XII α-1 chain, RAP1A and RAP39B were indicated to be associated with the progression and recurrence of PCa. In conclusion, the DEGs and hub genes identified in the present study may aid in determining the molecular mechanisms associated with PCa carcinogenesis and progression.
format Online
Article
Text
id pubmed-6896273
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-68962732019-12-09 Screening and identification of key biomarkers in prostate cancer using bioinformatics Li, Song Hou, Junqing Xu, Weibo Mol Med Rep Articles Prostate cancer (PCa) is the second most common cancer amongst males worldwide. In the current study, microarray datasets GSE3325 and GSE6919 from the Gene Expression Omnibus database were screened to identify candidate genes that are associated with the progression of PCa. A total of 273 differentially expressed genes (DEGs) were identified, which included 173 downregulated genes and 100 upregulated genes, and a protein-protein interaction network was constructed using Search Tool for the Retired of Interacting Genes. The enriched functions and pathways of the identified DEGs included cell adhesion, the negative regulation of cell proliferation, protein binding and focal adhesion. A total of 8 hub genes were identified, of which PDZ binding kinase, Krüppel-like factor 4, collagen type XII α-1 chain, RAP1A and RAP39B were indicated to be associated with the progression and recurrence of PCa. In conclusion, the DEGs and hub genes identified in the present study may aid in determining the molecular mechanisms associated with PCa carcinogenesis and progression. D.A. Spandidos 2020-01 2019-11-06 /pmc/articles/PMC6896273/ /pubmed/31746380 http://dx.doi.org/10.3892/mmr.2019.10799 Text en Copyright: © Li et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Li, Song
Hou, Junqing
Xu, Weibo
Screening and identification of key biomarkers in prostate cancer using bioinformatics
title Screening and identification of key biomarkers in prostate cancer using bioinformatics
title_full Screening and identification of key biomarkers in prostate cancer using bioinformatics
title_fullStr Screening and identification of key biomarkers in prostate cancer using bioinformatics
title_full_unstemmed Screening and identification of key biomarkers in prostate cancer using bioinformatics
title_short Screening and identification of key biomarkers in prostate cancer using bioinformatics
title_sort screening and identification of key biomarkers in prostate cancer using bioinformatics
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896273/
https://www.ncbi.nlm.nih.gov/pubmed/31746380
http://dx.doi.org/10.3892/mmr.2019.10799
work_keys_str_mv AT lisong screeningandidentificationofkeybiomarkersinprostatecancerusingbioinformatics
AT houjunqing screeningandidentificationofkeybiomarkersinprostatecancerusingbioinformatics
AT xuweibo screeningandidentificationofkeybiomarkersinprostatecancerusingbioinformatics